General Vs. Specific Use Final Guidance Emphasizes FDA Public Health Role
This article was originally published in The Gray Sheet
FDA re-emphasizes its role as a guardian of public health by strengthening language in the final version of its "Guidance for Industry on General/Specific Intended Use," leaving the door open for reviewers to consider public health issues in deciding when a specific use of a device is covered by a general claim.
You may also be interested in...
The House Commerce Committee has asked FDA Commissioner Jane Henney to review the agency's decision requiring Cryogen to submit a premarket approval application to expand the labeling of its First Option intrauterine cryosurgical probe to include specific references to endometrial ablation.
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.